Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout

investors.com/news/technology/novo-nordisk-akero-therapeutics-acquisition-mash-treatment

This story appeared on investors.com, 2025-10-09 14:52:41.273000.
The Entire Business World on a Single Page. Free to Use →